Post by Agilent Technologies

How do you study disease when it is not just one problem, but a complex system of interactions across cells, tissues, organs, and metabolism? That’s the question guiding the work of Hyungwon Choi, from the National University of Singapore. Read the full story here: https://bit.ly/4xj36mv Full video in this post: https://bit.ly/3OW5SNb From cardiometabolic disease to fatty liver disease and heart failure, Hyungwon Choi is using metabolomics, big data, and computational tools to better understand human health at a systems level. His team is also building knowledge from legacy mass spectrometry datasets to uncover new insights over time. Robust and reproducible measurement is essential for population-scale research—and that balance is critical to moving metabolomics closer to future therapies. #Metabolomics #SystemsBiology #MassSpectrometry #GreatScience